3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 1
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
102
Breast Neoplasms
79
Neoplasms
72
Melanoma
63
Neoplasm Metastasis
62
Leukemia, Myeloid, Acute
58
Ovarian Neoplasms
54
Lymphoma, Non-Hodgkin
53
Multiple Myeloma
51
Colorectal Neoplasms
50
Prostatic Neoplasms
49
Glioblastoma
48
Pancreatic Neoplasms
47
Lung Neoplasms
45
Recurrence
42
Carcinoma, Renal Cell
40
Leukemia, Lymphocytic, Chronic, B-Cell
37
Squamous Cell Carcinoma of Head and Neck
36
Triple Negative Breast Neoplasms
34
Myelodysplastic Syndromes
30
Lymphoma, Large B-Cell, Diffuse
28
Glioma
28
Stomach Neoplasms
27
Precursor Cell Lymphoblastic Leukemia-Lymphoma
27
Lymphoma, B-Cell
27
Brain Neoplasms
27
Lymphoma, Follicular
26
Endometrial Neoplasms
26
Lymphoma
25
Carcinoma, Hepatocellular
24
Interventions
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Active not recruiting
×
Ganglioglioma
×
Clear all
NCT03152318
2026-03-04
rQNestin
Dana-Farber Cancer Institute
Phase 1
Active not recruiting
62 enrolled